YuanBio Venture Capital
Jiangsubioventure.com.cn
Overview
Yuanbio Venture Capital is a leading healthcare investment firm focusing on early and growth stage investment opportunities. Headquartered in Suzhou bioBay, they look for highly innovative companies across the country and keeps a global view on the development of healthcare industry . Till now, there are over 190 companies in their investment portfolio, covering biotech, medical devices, IVD and healthcare services, and 19 of the companies are listed on the SRAT Board, HKEX and Nasdaq, delivering outstanding performance to their funds . YuanBio has been awarded as one of the top healthcare VCs in China for many consecutive years .
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Chengdu Zhenyu Biopharmaceutical Technology Co., Ltd. | May 2026 | Series A | Lead |
| Excalipoint Therapeutics | Mar 2026 | Seed | Lead |
| AccuPulse Medical Technology | Mar 2026 | VC Round | Co-investor |
| BCIFlex | Mar 2026 | Series A Extension | Co-investor |
| Allink Biotherapeutics | Dec 2025 | Series A Extension | Co-investor |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
